Search Within

Parastoo Bahrami Dahi

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (19)
Groups
  1. Bone Marrow Transplant (51)
  2. CTCR Scholars (51)
  3. Center for Hematologic Malignancies (51)
  4. Department of Medicine (51)
  5. GSK Faculty (51)
  6. Hematologic Malignancies, Division of (51)

More Groups

People
  1. Sergio Giralt (44)
  2. Miguel-Angel Perales (43)
  3. Craig Sauter (36)
  4. Doris Ponce (35)
  5. Esperanza Papadopoulos (35)
  6. Juliet Barker (35)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (8)
  6. 2019 (4)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (19)
  2. Blood (15)
  3. Bone Marrow Transplantation (5)
  4. Blood Advances (3)
  5. Journal of Clinical Investigation (3)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (21)
  2. American Society of Hematology (18)
  3. Nature Publishing Group (6)
  4. American Society for Clinical Investigation (3)
  5. American Association for the Advancement of Science (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (51)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4(+) immunity to mediate durable responses
    Journal Article

    Fabrizio, V. A.; Rodriguez-Sanchez, M. I.; Mauguen, A.; Dahi, P. B.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S. E.
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes
    Meeting Abstract

    Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV CTLS for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
    Journal Article

    Shah, G. L.; DeWolf, S.; Lee, Y. J.; Tamari, R.; Dahi, P. B.; Lavery, J. A.; Ruiz, J.; Devlin, S. M.; Cho, C.; Peled, J. U.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
    Journal Article

    Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Ex vivo T cell-depleted hematopoietic stem cell transplantation for adult patients with acute myelogenous leukemia in first and second remission: Long-term disease-free survival with a significantly reduced risk of graft-versus-host disease
    Journal Article

    Montoro, J.; Ceberio, I.; Hilden, P.; Maloy, M. A.; Barker, J.; Castro-Malaspina, H.; Dahi, P.; Koehne, G.; Perales, M. A.; Ponce, D.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of double unit cord blood transplants (dCBT) with 8/8 HLA-allele matched related (MRD) or unrelated donor (MUD) T-cell depleted (TCD) transplants in adults with myeloid malignancies: Comparable progression-free survival (PFS)
    Meeting Abstract

    Politikos, I.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; O'Reilly, R. J.; Scaradavou, A.; Castro-Malaspina, H.; Dahi, P. B.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save